This article describes the current role of PGx and reviews common practices in study design and analysis. Using our proprietary Personalised Medicine Simulation Tool, a case study is developed to illustrate some limitations of current practices and to demonstrate the importance of prospective planning for PGx research. Further challenges and opportunities for PGx are also considered. The paper is available online at Drug Discovery Today. Alternatively, please contact us for a reprint.